Conference Highlights

Engineers know that data is only as valuable as the decisions it drives. The Data-Driven Manufacturing Excellence Solutions track at the 2025 ISPE Pharma 4.0™ Conference will showcase how pharma organizations are moving from siloed operations to connected, data-first ecosystems—unlocking supply resiliency, efficiency, and innovation across the value chain.

In Pharma 4.0™, quality should no longer be reactive—it’s predictive, connected, and embedded in daily operations. The 2025 ISPE Pharma 4.0™ Conference, taking place 9–10 December in Barcelona, Spain, and virtually, will feature eight technical tracks, including the Data-Driven Quality Decisions track. This track will showcase how organizations are rethinking quality frameworks with digital tools that ensure compliance, improve efficiency, and enable decision-making in real time.

The pharmaceutical industry is under constant pressure to expand capacity, accelerate time-to-market, and ensure reliable access to critical medicines. As more therapies gain regulatory approval and blockbuster drugs scale rapidly, the need for smarter, more resilient facilities has never been greater. That is why ISPE is particularly excited about the Innovative Facility Design track at the 2025 ISPE Pharma 4.0™ Conference, which takes place 9–10 December in Barcelona and virtually.

The pace of innovation—digital joined with operational excellence—in the life sciences industry shows signs of improvement. Artificial intelligence, robotics, advanced analytics, smart facilities design and innovation culture are no longer “future concepts”—they are deeply transforming pharmaceutical development, manufacturing and the whole supply chain. Alongside many exciting opportunities come real challenges: how do we ensure quick-wins and tangible benefits? How can organizations reach adequate compliance? How do we balance agility with data integrity and data reliability? How do we design new facilities that are both innovative and sustainable?

Artificial Intelligence isn’t just theory anymore—it’s revolutionizing pharmaceutical operations today. At this year’s 2025 ISPE Pharma 4.0™ Conference, the AI Case Studies: Benefits and Challenges track features four case studies that bring to life both the promise and the pitfalls of deploying AI in quality, lab, manufacturing, and global investigations. Below are highlights of some sessions attendees won’t want to miss—and what they’ll learn.

For the first time in ISPE Pharma 4.0™ Conference history, ISPE will dedicate an entire track for the 2025 ISPE Pharma 4.0™ Conference to Process Analytical Technology (PAT)—in recognition of how central it has become to digital transformation in pharmaceutical manufacturing. The promise of PAT goes far beyond data collection of data analyzation. Its real value lies in enabling better decision-making, supporting continuous processes, improving supply chain resilience, and designing and embedding quality directly into manufacturing process and supporting systems.

The 2025 ISPE Pharma 4.0™ Conference will take place 9–10 December in Barcelona, Spain, and virtually. In the videos and transcripts that follow, International Program Committee Member Line Lundsberg-Nielsen highlights several planned technical tracks and shares what she is most looking forward to at this year’s conference.

The 2025 ISPE Pharma 4.0™ Conference is fast-approaching, taking place from 9–10 December in Barcelona, Spain, and virtually. In the videos and transcripts that follow, International Program Committee Members Vinzenz Zauner, Project Manager with Zauner Consulting and Giuseppe Di Vietri, Operation Technology, Digital, and Data Associate Director with Merck Serono S.P.A., highlight the challenges the conference will help pharmaceutical companies address, exciting or high-impact themes that will be covered, and what this conference will help attendees solve for their employers.

The 2025 ISPE Pharma 4.0™ Conference will take place from 9–10 December in Barcelona, Spain, and virtually. In the video and transcript that follows, International Program Committee Member Alicia Tébar, General Manager and Founder of QbD Pharmaceutical Services SL, highlights industry challenges the conference will help to address, exciting topics she looks forward to exploring, and what employees can learn from the conference to take back to their teams.